BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2460578)

  • 1. MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site.
    Oksenberg JR; Judd AK; Ko C; Lim M; Fernandez R; Schoolnik GK; Steinman L
    J Exp Med; 1988 Nov; 168(5):1855-64. PubMed ID: 2460578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.
    De Magistris MT; Romano M; Bartoloni A; Rappuoli R; Tagliabue A
    J Exp Med; 1989 May; 169(5):1519-32. PubMed ID: 2469760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
    Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
    J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of T cell epitopes on the S1 subunit of pertussis toxin.
    Kim KJ; McKinness S; Manclark CR
    J Immunol; 1990 May; 144(9):3529-34. PubMed ID: 1691761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
    Chong P; Zobrist G; Sia C; Loosmore S; Klein M
    Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
    J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
    Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Heron I
    Infect Immun; 1993 Jan; 61(1):56-63. PubMed ID: 7678102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.
    Kim KJ; Burnette WN; Sublett RD; Manclark CR; Kenimer JG
    Infect Immun; 1989 Mar; 57(3):944-50. PubMed ID: 2465274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA; Raupach B; Szulczynski M; Marzillier J
    Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1347-51. PubMed ID: 2304902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of B-cell epitopes on the S4 subunit of pertussis toxin.
    Ibsen PH; Holm A; Petersen JW; Olsen CE; Heron I
    Infect Immun; 1993 Jun; 61(6):2408-18. PubMed ID: 7684728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering bacterial toxin for the development of new vaccine against pertussis.
    Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.
    Chong P; Sydor M; Wu E; Zobrist G; Boux H; Klein M
    Mol Immunol; 1991 Mar; 28(3):239-45. PubMed ID: 2017195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.